SCHEMBL9616705

SCHEMBL9616705

CCN(CC)CCCNc1nnc2ccccc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.56
TSHR P16473 1/20 0.56
CACNA2D1 P54289 2/20 0.55
GAA P10253 2/20 0.51
POLB P06746 2/20 0.51
SLC2A1 P11166 1/20 0.47
TP53 P04637 1/20 0.46
BCHE P06276 2/20 0.45
FLT3 P36888 5/20 0.45
ACHE P22303 1/20 0.44
KDM1A O60341 1/20 0.43
EHMT2 Q96KQ7 1/20 0.43
RCOR1 Q9UKL0 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
APAF1 O14727 1/20 0.43
NPC1 O15118 1/20 0.43
MITF O75030 1/20 0.43
NSD2 O96028 1/20 0.43
MAPT P10636 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11861178 0.79 POLB (0.71) TOP2ACACNA2D1GAAPOLBSLC2A1
SCHEMBL2326504 0.79 TP53 (0.52) TOP2ATSHRCACNA2D1GAAPOLB
SCHEMBL6366253 0.77 TSHR (0.53) TOP2ATSHRCACNA2D1GAAPOLB
SCHEMBL9728588 0.76 KDM4E (0.61) TSHRGAAPOLBMITFMAPT
SCHEMBL4726253 0.75 CACNA2D1 (0.91) TOP2ATSHRCACNA2D1GAAPOLB
Diethylamine SCHEMBL9616787 0.74 APP (0.47) SLC2A1BCHEACHEKMT2AKDM4E
Hydrochloric Acid SCHEMBL2683722 0.73 CACNA2D1 (0.89) TOP2ACACNA2D1GAAPOLBSLC2A1
SCHEMBL8890767 0.72 POLB (0.61) TOP2ACACNA2D1GAAPOLBSLC2A1
SCHEMBL1089720 0.72 MRGPRX1 (0.58) TOP2ATSHRCACNA2D1GAAPOLB
SCHEMBL12058552 0.72 ELANE (0.39) TOP2AGAABCHEACHEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017075052-A1 USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES DELMAR PHARMACEUTICALS, INC. (CA) 2017-05-04 WO disclosed
WO-2017042634-A2 USE OF DIANHYDROGALACTITOL OR DERIVATIVES AND ANALOGS THEREOF FOR TREATMENT OF NON-SMALL-CELL LUNG CARCINOMA, GLIOBLASTOMA, AND OVARIAN CARCINOMA BY INDUCTION OF DNA DAMAGE AND STALLING OF CELL CYCLE DEL MAR PHARMACEUTICALS (CA) 2017-03-16 WO disclosed
EP-2983674-A1 THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS Brown, Dennis M. (US) 2016-02-17 EP disclosed
EP-2872161-A2 METHODS FOR TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS EMPLOYING DIANHYDROGALACTITOL, DIACETYLDIANHYDROGALACTITOL, DIBROMODULCITOL, OR ANALOGS OR DERIVATIVES THEREOF Del Mar Pharmaceuticals (CA) 2015-05-20 EP disclosed
WO-2014168986-A1 THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS BROWN DENNIS M (US) 2014-10-16 WO disclosed
WO-2014004376-A2 METHODS FOR TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS EMPLOYING DIANHYDROGALACTITOL, DIACETYLDIANHYDROGALACTITOL, DIBROMODULCITOL, OR ANALOGS OR DERIVATIVES THEREOF DEL MAR PHARMACEUTICALS (CA) 2014-01-03 WO disclosed
EP-0478545-A4 1,2,4-BENZOTRIAZINE OXIDES AS RADIOSENSITIZERS AND SELECTIVE CYTOTOXIC AGENTS STANFORD RES INST INT (US) 1992-08-05 EP disclosed
EP-0478545-A1 1,2,4-BENZOTRIAZINE OXIDES AS RADIOSENSITIZERS AND SELECTIVE CYTOTOXIC AGENTS SRI INTERNATIONAL (US) 1992-04-08 EP disclosed
WO-1991004028-A1 1,2,4-BENZOTRIAZINE OXIDES AS RADIOSENSITIZERS AND SELECTIVE CYTOTOXIC AGENTS SRI INTERNATIONAL (US) 1991-04-04 WO disclosed